Patents by Inventor Zhaoqing Wang

Zhaoqing Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assay for Assessing Heart Failure
    Publication number: 20220317133
    Abstract: A method of immunoassay for detecting and/or monitoring a cardiovascular disease in a patient and/or assessing the likelihood of or the severity of a cardiovascular disease in a patient, comprising contacting a biofluid sample from a patient with a monoclonal antibody that specifically binds to a C-terminal epitope of the C5 domain of the ?3 chain of type VI collagen, and/or contacting a biofluid sample from the patient with a monoclonal antibody that specifically binds to a C-terminal neo-epitope of the N-terminal propeptide of type III collagen.
    Type: Application
    Filed: June 5, 2020
    Publication date: October 6, 2022
    Applicants: Nordic Bioscience A/S, Bristol-Myers Squibb Company, The Trustees of the University of Pennsylvania
    Inventors: Federica Genovese, Morten Karsdal, Lei Zhao, David Gordon, Zhaoqing Wang, Julio Alonso Chirinos Medina
  • Organic anion transport proteins
    Patent number: 7795392
    Abstract: The current invention discloses nucleic acid and amino acid sequences for novel organic anion transfer proteins (“OATPs”). The invention encompasses the OATPs described herein, together with vectors containing the cDNA sequences, host cells containing the vectors and polypeptides having all or part of an OATP. Also encompasses are uses for OATPs for targeting drugs to specific organs and for modulating the concentration of endogenous substrates.
    Type: Grant
    Filed: May 17, 2007
    Date of Patent: September 14, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Todd G. Kirchgessner, Bonnie Hsiang, Yingjie Zhu, Yuli Wu, Zhaoqing Wang, Jean S. Lynch, Xin Huang, Wen-Pin Yang
  • Novel organic anion transport proteins
    Publication number: 20070243586
    Abstract: The current invention discloses nucleic acid and amino acid sequences for novel organic anion transfer proteins (“OATPs”). The invention encompasses the OATPs described herein, together with vectors containing the cDNA sequences, host cells containing the vectors and polypeptides having all or part of an OATP. Also encompasses are uses for OATPs for targeting drugs to specific organs and for modulating the concentration of endogenous substrates.
    Type: Application
    Filed: May 17, 2007
    Publication date: October 18, 2007
    Inventors: Todd Kirchgessner, Bonnie Hsiang, Yingjie Zhu, Yuli Wu, Zhaoqing Wang, Jean Lynch, Xin Huang, Wen-Pin Yang
  • Organic anion transport proteins
    Patent number: 6692934
    Abstract: The current invention discloses nucleic acid and amino acid sequences for novel organic anion transfer proteins (“OATPs”). The invention encompasses the OATPs described herein, together with vectors containing the cDNA sequences, host cells containing the vectors and polypeptides having all or part of an OATP. Also encompasses are uses for OATPs for targeting drugs to specific organs and for modulating the concentration of endogenous substrates.
    Type: Grant
    Filed: May 19, 2000
    Date of Patent: February 17, 2004
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Todd G. Kirchgessner, Bonnie Hsiang, Yingjie Zhu, Yuli Wu, Zhaoqing Wang, Jean S. Lynch, Xin Huang, Wen-Pin Yang
  • GlyT-1 inhibitors
    Patent number: 6667336
    Abstract: The invention provides a pharmaceutical for treatment of neurological and neuropsychiatric disorders comprising a compound of the formula: or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: December 23, 2003
    Assignees: NPS Allelix Corp., Allelix Neuroscience, Inc.
    Inventors: Zhaoqing Wang, William Delaney, Ashok Tehim, Shawn Maddaford, Ian Egle, Richard Schumacher, Allen T. Hopper
  • GLYT-1 INHIBITORS
    Publication number: 20030176489
    Abstract: The invention provides a pharmaceutical for treatment of neurological and neuropsychiatric disorders comprising a compound of the formula: 1
    Type: Application
    Filed: February 15, 2002
    Publication date: September 18, 2003
    Inventors: Zhaoqing Wang, William Delaney, Ashok Tehim, Shawn Maddaford, Ian Egle, Richard Schumacher, Allen T. Hopper